Evidence map›Paper›PMID 25903468›Full record

ReviewWiley interdisciplinary reviews. Nanomedicine and nanobiotechnology

Probing stem cell behavior using nanoparticle-based approaches.

Sahishnu Patel, Ki-Bum Lee

Abstract readReview
In one paragraph

Review in Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sahishnu PatelDepartment of Chemistry and Chemical Biology, Rutgers, The State University of New Jersey, Piscataway, NJ, USA.
Ki-Bum LeeDepartment of Chemistry and Chemical Biology, Rutgers, The State University of New Jersey, Piscataway, NJ, USA.
Rutgers, The State University of New Jersey · US

Funding

Combinatorial approaches for studying multiple cues regulating human pluripotentDP2OD006462 · OD · RUTGERS, THE STATE UNIV OF N.J. · PI LEE, KIBUM · 2009 to 2009
$2.3M
Novel magnetic core/shell nanoparticle-based stem cell therapy to direct neural sR21NS085569 · NINDS · RUTGERS, THE STATE UNIV OF N.J. · PI LEE, KIBUM · 2013 to 2014
$421k
NCCDPHP CDC HHS 1DP20D006462-01NIH HHS DP2 OD006462NINDS NIH HHS 1R21NS085569-01NINDS NIH HHS R21 NS085569
6 · The paper itself

Abstract

Stem cells hold significant clinical potential to treat numerous debilitating diseases and injures that currently have no treatment plan. While several advances have been made in developing stem cell platforms and methods to induce their differentiation, there are two critical aspects need to be addressed: (1) efficient delivery of nucleic acids and small molecules for stem cell differentiation, and (2) effective, noninvasive, and real-time tracking of transplanted stem cells. To address this, there has been a trend of utilizing various types of nanoparticles to not only deliver biomolecules to targeted site but also track the location of transplanted stem cells in real time. Over the past decade, various types of nanoparticles, including magnetic nanoparticles, silica nanoparticles, quantum dots, and gold nanoparticles, have been developed to serve as vehicles for targeted biomolecule delivery. In addition of being biocompatible without causing adverse side effect to stem cells, these nanoparticles have unique chemical and physical properties that allow tracking and imaging in real time using different imaging instruments that are commonly found in hospitals. A summary of the landmark and progressive demonstrations that utilize nanoparticles for stem cell application is described.

Indexed as

AnimalsBiocompatible MaterialsCell DifferentiationCell TrackingDrug Delivery SystemsGoldHumansMagnetite NanoparticlesMesenchymal Stem CellsMiceNanoparticlesQuantum DotsSilicon DioxideStem CellsBiocompatible MaterialsGoldMagnetite NanoparticlesSilicon Dioxide

Identifiers

PMID25903468
PMCPMC5808881
OpenAlexW1562805413

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.